ENDO BIOLOGICS LIMITED – Trademark Portfolio
Entity Type: 24
ENDO BIOLOGICS LIMITED holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 4 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include XIAFLEX, BUTT FIRST, and XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM. The owner is based in BALLSBRIDGE.
FIRST FLOOR, MINERVA HOUSE
SIMMONSCOURT ROAD
BALLSBRIDGE 4 , IE
Showing of trademarks Trademarks
Trademark Classifications
ENDO BIOLOGICS LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does ENDO BIOLOGICS LIMITED have?
ENDO BIOLOGICS LIMITED has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does ENDO BIOLOGICS LIMITED file in?
ENDO BIOLOGICS LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ENDO BIOLOGICS LIMITED's most well-known trademarks?
ENDO BIOLOGICS LIMITED's registered trademark portfolio includes well-known marks such as XIAFLEX, BUTT FIRST, and XIAFLEX COLLAGENASE CLOSTRIDIUM HISTOLYTICUM. These are among 4 currently registered trademarks in the portfolio.
What is ENDO BIOLOGICS LIMITED's trademark registration success rate?
ENDO BIOLOGICS LIMITED has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.